tradingkey.logo
搜索

Procept Biorobotics Corp

PRCT
添加自选
22.190USD
-1.280-5.45%
交易中 美东报价延迟15分钟
1.24B总市值
亏损市盈率 TTM

Procept Biorobotics Corp

22.190
-1.280-5.45%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-5.45%

5天

+6.43%

1月

-20.35%

6月

-29.47%

今年开始到现在

-29.47%

1年

-60.77%

关键数据
23.830今开
24.080最高
371.17K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.66%换手率
23.470昨收
21.995最低
5.68M成交额
亏损市盈率静
3.26市净率
0.00%股息率 TTM
-20.36%ROA
66.85052周最高
1.20量比
-91.41M净利润
55.87M总股本
-1.8301每股收益TTM
0.85Beta
-27.81%ROE
19.35052周最低
8.88%振幅
64.89%毛利率
1.24B总市值
-3.26回报/风险
3.78%风险率

TradingKey Procept Biorobotics Corp股票评分

单位: USD 更新时间: 2026-07-01

操作建议

Procept Biorobotics Corp当前公司基本面数据相对非常健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名49/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价32.54。中期看,股价处于平稳状态。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Procept Biorobotics Corp评分

相关信息

行业排名
49 / 204
全市场排名
146 / 4564
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Procept Biorobotics Corp亮点

亮点风险
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
业绩高增长
公司营业收入稳步增长,连续3年增长126.19%
估值高估
公司最新PE估值-12.82,处于3年历史高位
机构减仓
最新机构持股65.01M股,环比减少1.54%
史蒂文·科恩持仓
明星投资者史蒂文·科恩持仓,最新持仓市值1.07M

分析师目标

根据 16 位分析师
买入
评级
32.538
目标均价
+44.10%
涨幅空间

Procept Biorobotics Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Procept Biorobotics Corp简介

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
公司代码PRCT
公司Procept Biorobotics Corp
CEOWood (Larry L)
网址https://www.procept-biorobotics.com/

常见问题

Procept Biorobotics Corp(PRCT)的当前股价是多少?

Procept Biorobotics Corp(PRCT)的当前股价是 23.47。

Procept Biorobotics Corp的股票代码是什么?

Procept Biorobotics Corp的股票代码是PRCT。

Procept Biorobotics Corp股票的52周最高点是多少?

Procept Biorobotics Corp股票的52周最高点是66.85。

Procept Biorobotics Corp股票的52周最低点是多少?

Procept Biorobotics Corp股票的52周最低点是19.35。

Procept Biorobotics Corp的市值是多少?

Procept Biorobotics Corp的市值是1.34B。

现在Procept Biorobotics Corp(PRCT)的股票是买入、持有还是卖出?

根据分析师评级,Procept Biorobotics Corp(PRCT)的总体评级为买入,目标价格为32.54。

Procept Biorobotics Corp(PRCT)股票的每股收益(EPS TTM)是多少

Procept Biorobotics Corp(PRCT)股票的每股收益(EPS TTM)是-1.72。